Human CD20 (Research Grade Rituximab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Supplier:  R&D Systems MAB9575100

Catalog No. MAB9575100

Description

CD20 Monoclonal specifically detects CD20 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: CD20
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Host Species: Human
• Purification Method: Protein A or G purified from cell culture supernatant
• Primary or Secondary: Primary
• Test Specificity: Detects Human CD20 based on Rituximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Rituximab. This product is for research use only.
• Target Species: Human
• Form: Supernatant

• Applications: Flow Cytometry, CyTOF
• Clone: Hu2
• Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
• Gene Alias: B1, B-lymphocyte antigen CD20, B-lymphocyte cell-surface antigen B1, B-lymphocyte surface antigen B1, Bp35, Bp35MGC3969, CD20, CD20 antigen, CD20 receptor, CD20S7, CVID5, LEU-16, Leukocyte surface antigen Leu-16, Ly-44, Membrane-spanning 4-domains subfamily A member 1, membrane-spanning 4-domains, subfamily A, member 1, MS4A1, MS4A2, S7
• Immunogen: Human CD20
• Quantity: 100 μg
• Gene ID (Entrez): 931
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
• Isotype: IgG1